Early recognition and optimal treatment of acute confusion in patients with advanced cancer.
- Conditions
- Delirium in patients with advanced cancerTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
- Registration Number
- EUCTR2009-013403-55-NL
- Lead Sponsor
- VU university medical center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
• Patient has been diagnosed with advanced cancer;
• Age = 18;
• Patient or his / her significant other speaks Dutch fluently.
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 100
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 100
• Delirium is due to alcohol withdrawal;
• Patient has been diagnosed with glaucoma, Parkinson’s disease or dementia;
• Patient is being treated with other neuroleptic medication or lithium (except for low dose neuroleptics used in the treatment of neuropathic pain;
• Patient has another psychiatric disorder that is considered (by investigator) to interfere withassessment of delirium;
• Patient had a QTc-interval of > 480 msec on ECG made on admission;
• Patient has a history of neuroleptic malignant syndrome;
• Patient has a history of convulsions.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method